KR20170131449A - Hcv의 거대고리 단백질 가수분해효소 저해제 제조를 위한 방법 및 중간물질 - Google Patents
Hcv의 거대고리 단백질 가수분해효소 저해제 제조를 위한 방법 및 중간물질 Download PDFInfo
- Publication number
- KR20170131449A KR20170131449A KR1020177026974A KR20177026974A KR20170131449A KR 20170131449 A KR20170131449 A KR 20170131449A KR 1020177026974 A KR1020177026974 A KR 1020177026974A KR 20177026974 A KR20177026974 A KR 20177026974A KR 20170131449 A KR20170131449 A KR 20170131449A
- Authority
- KR
- South Korea
- Prior art keywords
- compound
- formula
- compounds
- xviia
- mol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/82—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
- C12P7/22—Preparation of oxygen-containing organic compounds containing a hydroxy group aromatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/40—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07C67/31—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by introduction of functional groups containing oxygen only in singly bound form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
- C12P41/001—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by metabolizing one of the enantiomers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/24—Preparation of oxygen-containing organic compounds containing a carbonyl group
- C12P7/26—Ketones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C233/60—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C233/61—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C69/757—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Analytical Chemistry (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP15161431 | 2015-03-27 | ||
EP15161431.0 | 2015-03-27 | ||
PCT/IB2016/051720 WO2016157058A1 (en) | 2015-03-27 | 2016-03-25 | Processes and intermediates for preparing a macrocyclic protease inhibitor of hcv |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20170131449A true KR20170131449A (ko) | 2017-11-29 |
Family
ID=52737010
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020177026974A KR20170131449A (ko) | 2015-03-27 | 2016-03-25 | Hcv의 거대고리 단백질 가수분해효소 저해제 제조를 위한 방법 및 중간물질 |
Country Status (15)
Country | Link |
---|---|
US (1) | US20180093943A1 (zh) |
EP (1) | EP3274324A1 (zh) |
JP (1) | JP2018517661A (zh) |
KR (1) | KR20170131449A (zh) |
CN (1) | CN107429270A (zh) |
AU (1) | AU2016241924A1 (zh) |
BR (1) | BR112017019898A2 (zh) |
CA (1) | CA2976175A1 (zh) |
EA (1) | EA201792114A1 (zh) |
HK (1) | HK1247246A1 (zh) |
IL (1) | IL253899A0 (zh) |
MA (1) | MA41812A (zh) |
MX (1) | MX2017012348A (zh) |
SG (1) | SG11201707594SA (zh) |
WO (1) | WO2016157058A1 (zh) |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20070211A1 (es) | 2005-07-29 | 2007-05-12 | Medivir Ab | Compuestos macrociclicos como inhibidores del virus de hepatitis c |
JO2768B1 (en) * | 2005-07-29 | 2014-03-15 | تيبوتيك فارماسيوتيكالز ليمتد | Large cyclic inhibitors of hepatitis C virus |
EP2121674B1 (en) | 2007-02-01 | 2010-05-12 | Tibotec Pharmaceuticals | Processes and intermediates for preparing a macrocyclic protease inhibitor of hcv |
US8048862B2 (en) | 2008-04-15 | 2011-11-01 | Intermune, Inc. | Macrocyclic inhibitors of hepatitis C virus replication |
ES2429013T3 (es) | 2008-12-23 | 2013-11-12 | Janssen Pharmaceuticals, Inc. | Procedimientos e intermedios para la preparación de un inhibidor macrocíclico de la proteasa de VHC |
EP3239129A1 (en) | 2010-03-16 | 2017-11-01 | Janssen Pharmaceuticals, Inc. | Processes and intermediates for preparing a macrocyclic protease inhibitor of hcv |
JP2014527061A (ja) * | 2011-08-24 | 2014-10-09 | グラクソスミスクライン エルエルシー | C型肝炎の組合せ治療 |
KR20140063726A (ko) | 2011-09-22 | 2014-05-27 | 얀센 파마슈티칼즈, 인코포레이티드 | Hcv의 거대고리 단백질 분해효소 억제제의 제조 방법 및 중간물질 |
BR112014009849A2 (pt) | 2011-10-28 | 2016-07-05 | Janssen Pharmaceuticals Inc | processo melhorado para preparação de intermediário do inibidor de protease macrocíclico tmc 435 |
-
2016
- 2016-03-24 MA MA041812A patent/MA41812A/fr unknown
- 2016-03-25 AU AU2016241924A patent/AU2016241924A1/en not_active Abandoned
- 2016-03-25 MX MX2017012348A patent/MX2017012348A/es unknown
- 2016-03-25 CA CA2976175A patent/CA2976175A1/en not_active Abandoned
- 2016-03-25 EA EA201792114A patent/EA201792114A1/ru unknown
- 2016-03-25 WO PCT/IB2016/051720 patent/WO2016157058A1/en active Application Filing
- 2016-03-25 BR BR112017019898A patent/BR112017019898A2/pt not_active Application Discontinuation
- 2016-03-25 KR KR1020177026974A patent/KR20170131449A/ko unknown
- 2016-03-25 CN CN201680018539.7A patent/CN107429270A/zh active Pending
- 2016-03-25 JP JP2017550186A patent/JP2018517661A/ja active Pending
- 2016-03-25 EP EP16715347.7A patent/EP3274324A1/en not_active Withdrawn
- 2016-03-25 SG SG11201707594SA patent/SG11201707594SA/en unknown
- 2016-03-25 US US15/559,910 patent/US20180093943A1/en not_active Abandoned
-
2017
- 2017-08-08 IL IL253899A patent/IL253899A0/en unknown
-
2018
- 2018-05-17 HK HK18106372.5A patent/HK1247246A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
CN107429270A (zh) | 2017-12-01 |
HK1247246A1 (zh) | 2018-09-21 |
BR112017019898A2 (pt) | 2018-06-12 |
EA201792114A1 (ru) | 2018-01-31 |
JP2018517661A (ja) | 2018-07-05 |
EP3274324A1 (en) | 2018-01-31 |
AU2016241924A1 (en) | 2017-08-24 |
WO2016157058A1 (en) | 2016-10-06 |
SG11201707594SA (en) | 2017-10-30 |
CA2976175A1 (en) | 2016-10-06 |
US20180093943A1 (en) | 2018-04-05 |
MX2017012348A (es) | 2017-12-14 |
MA41812A (fr) | 2018-01-30 |
IL253899A0 (en) | 2017-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1285843A (zh) | 化合物 | |
TW201323406A (zh) | 製備β3-激動劑及中間物之方法 | |
JP2009173665A (ja) | ベンゾオキサジン誘導体の製造法およびその製造中間体 | |
JP6728239B2 (ja) | 3−(6−クロロ−3−オキソ−3,4−ジヒドロ−(2h)−1,4−ベンゾキサジン−4−イル)プロパン酸誘導体、およびその、kmo阻害剤としての使用 | |
CN1482908A (zh) | 吲哚并咔唑的相转移催化苷化方法 | |
CN1280258C (zh) | 4,5-二氨基莽草酸衍生物的制备方法 | |
TW200831478A (en) | Chromane derivatives, synthesis thereof, and intermediates thereto | |
KR20170131449A (ko) | Hcv의 거대고리 단백질 가수분해효소 저해제 제조를 위한 방법 및 중간물질 | |
KR20160075816A (ko) | 피리미딘일사이클로펜테인 화합물의 제조 방법 | |
Kurokawa et al. | Both enantiomers of N-Boc-indoline-2-carboxylic esters | |
JPH06237790A (ja) | ヘテロ−二環式アルコールエナンチオマーの酵素による立体選択的製造方法 | |
CN1383427A (zh) | 制备n6-取代的脱氮杂一腺苷衍生物的方法 | |
KR101976891B1 (ko) | 효소를 사용하는 2 고리성 화합물의 광학 분할 방법 | |
WO2011054773A1 (en) | Novel lactam compounds | |
Fischer et al. | Efficient synthesis of either enantiomer of ethyl 5‐hydroxyhept‐6‐enoate | |
JP4899022B2 (ja) | ネプラノシンaの新規製造方法及び中間体 | |
Yamada et al. | Optically active cyclohexene derivative as a new antisepsis agent: an efficient synthesis of ethyl (6R)-6-[N-(2-chloro-4-fluorophenyl) sulfamoyl] cyclohex-1-ene-1-carboxylate (TAK-242) | |
Hameršak et al. | Chemoenzymatic synthesis of all four cytoxazone stereoisomers | |
EP3298010B1 (en) | 3-(5-chloro-2-oxo-2,3-dihydro-1,3-benzothiazol-3-yl) propanoic acid derivatives and their use as kmo inhibitors | |
EP2684863B1 (en) | Iodoarene derivative, method for producing optically active spirolactone compound using same, and method for producing optically active cyclization adduct | |
JP4135258B2 (ja) | 新規化合物、その製造方法及び中間体 | |
JP3410452B2 (ja) | 光学活性イノシトールトリフォスフェートの製造法 | |
Yoshizumi et al. | Potent and orally active ETA selective antagonists with 5, 7-diarylcyclopenteno [1, 2-b] pyridine-6-carboxylic acid structures | |
JP2020019774A (ja) | ネビボロールの合成方法及びその中間化合物 | |
JP2000281625A (ja) | 光学活性な1−アシルオキシ−3−ヒドロキシ化合物の製造方法 |